Related Experiment Videos
Docetaxel-related skin, nail, and vascular toxicity
Gregory D Leonard1, Jo Anne Zujewski
1Medical Oncology Clinical Research Unit, National Cancer Institute, National Institutes of Health, Bethesda, MD 20892-1960, USA. leonardg@mail.nih.gov
The Annals of Pharmacotherapy
|February 5, 2003
Abstract
No abstract available in PubMed .
Related Concept Videos
Articles linked to this work by shared authors, journal, and citation graph.
Knowledge Summaries for Comprehensive Breast Cancer Control: Feedback From Target Audiences in Kenya.
Journal of global oncology·2019
Building a Network of Health Professionals for Breast and Cervical Cancer Control in the Andean Region.
Journal of global oncology·2018
Knowledge Summaries for Comprehensive Breast Cancer Control.
Journal of global oncology·2018
Apixaban Dose Selection in Kidney Failure: Reconciling Pharmacokinetics and Clinical Outcomes.
The Annals of pharmacotherapy·2026
Impact of Duration of Intravenous Octreotide Infusion on Achieving Hemostasis in Patients With Acute Variceal Hemorrhage.
The Annals of pharmacotherapy·2026
Prediction of Early Heparin Response in Patients With Venous Thromboembolism.
The Annals of pharmacotherapy·2026
EGFR kinase inhibitors from novel thiazole derivatives: synthesis, anticolon cancer, docking, and ADME studies.
Future medicinal chemistry·2026
Beyond the ceiling: A critical analysis of microRNA research in cutaneous T-cell lymphoma and a roadmap forward.
The Journal of investigative dermatology·2026
Tumor-Secreted ADAMTSL4 Activates Latent TGFβ1 to Drive Cancer Cachexia.
Cancer discovery·2026
Targeting glutaminase (GLS) to suppress CXCL8 secretion and sensitize esophageal squamous cell carcinoma to immunotherapy.
Journal of chemotherapy (Florence, Italy)·2026